Total Payments
$8,706
2024 Payments
$117.06
Companies
32
Transactions
141
Medicare Patients
2,129
Medicare Billing
$209,948
Payment Breakdown by Category
Consulting$3,825 (43.9%)
Travel$2,562 (29.4%)
Food & Beverage$2,283 (26.2%)
Other$23.78 (0.3%)
Education$12.74 (0.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Consulting Fee | $3,825 | 1 | 43.9% |
| Travel and Lodging | $2,562 | 6 | 29.4% |
| Food and Beverage | $2,283 | 132 | 26.2% |
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $23.78 | 1 | 0.3% |
| Education | $12.74 | 1 | 0.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| ABBVIE INC. | $5,171 | 29 | $0 (2024) |
| Abbott Laboratories | $1,851 | 7 | $0 (2019) |
| Novartis Pharmaceuticals Corporation | $305.63 | 23 | $0 (2022) |
| LivaNova USA, Inc. | $181.82 | 7 | $0 (2019) |
| Teva Pharmaceuticals USA, Inc. | $159.24 | 24 | $0 (2022) |
| Genentech USA, Inc. | $145.92 | 1 | $0 (2018) |
| ACADIA Pharmaceuticals Inc | $97.80 | 5 | $0 (2022) |
| CSL Behring | $87.47 | 5 | $0 (2019) |
| Eisai Inc. | $80.78 | 5 | $0 (2024) |
| GE HEALTHCARE | $66.54 | 3 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $117.06 | 6 | ABBVIE INC. ($85.18) |
| 2023 | $108.34 | 4 | AbbVie Inc. ($71.29) |
| 2022 | $517.29 | 50 | Novartis Pharmaceuticals Corporation ($168.12) |
| 2021 | $26.90 | 2 | Eisai Inc. ($15.08) |
| 2020 | $149.87 | 9 | ACADIA Pharmaceuticals Inc ($37.09) |
| 2019 | $7,375 | 57 | AbbVie, Inc. ($4,850) |
| 2018 | $322.58 | 10 | Genentech USA, Inc. ($145.92) |
| 2017 | $89.19 | 3 | LivaNova USA, Inc. ($62.63) |
All Payment Transactions
141 individual payment records from CMS Open Payments — Page 1 of 6
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 07/31/2024 | ABBVIE INC. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $19.66 | General |
| Category: BOTOX THERAPEUTIC | ||||||
| 07/23/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $20.05 | General |
| Category: NEUROSCIENCE | ||||||
| 06/10/2024 | Eisai Inc. | Leqembi (Drug) | Food and Beverage | In-kind items and services | $18.12 | General |
| Category: Neurology | ||||||
| 05/16/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $23.20 | General |
| Category: NEUROSCIENCE | ||||||
| 02/14/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $13.76 | General |
| Category: PAIN | ||||||
| 02/07/2024 | ABBVIE INC. | UBRELVY (Drug), BOTOX | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: NEUROSCIENCE | ||||||
| 11/26/2023 | UCB, Inc. | Briviact (Drug) | Food and Beverage | In-kind items and services | $37.05 | General |
| Category: Neurology | ||||||
| 09/25/2023 | AbbVie Inc. | BOTOX (Biological) | Food and Beverage | In-kind items and services | $28.48 | General |
| Category: NEUROSCIENCE | ||||||
| 08/18/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.64 | General |
| Category: NEUROSCIENCE | ||||||
| 02/04/2023 | AbbVie Inc. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $21.17 | General |
| Category: NEUROSCIENCE | ||||||
| 12/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $4.12 | General |
| Category: Central Nervous System | ||||||
| 12/09/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $9.62 | General |
| Category: Central Nervous System | ||||||
| 12/09/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $7.56 | General |
| Category: Central Nervous System | ||||||
| 11/18/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $20.46 | General |
| Category: NEUROSCIENCE | ||||||
| 11/16/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $25.71 | General |
| Category: NEUROSCIENCE | ||||||
| 11/15/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $8.69 | General |
| Category: Central Nervous System | ||||||
| 11/10/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $22.36 | General |
| Category: NEUROSCIENCE | ||||||
| 11/02/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $14.40 | General |
| Category: NEUROSCIENCE | ||||||
| 10/18/2022 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $9.49 | General |
| Category: NEUROSCIENCE | ||||||
| 09/27/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $5.94 | General |
| Category: Central Nervous System | ||||||
| 09/19/2022 | ABBVIE INC. | QULIPTA (Drug) | Food and Beverage | In-kind items and services | $13.05 | General |
| Category: NEUROSCIENCE | ||||||
| 09/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $15.12 | General |
| Category: Central Nervous System | ||||||
| 09/14/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $2.61 | General |
| Category: Central Nervous System | ||||||
| 09/06/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug) | Food and Beverage | In-kind items and services | $11.83 | General |
| Category: NEUROSCIENCE | ||||||
| 08/22/2022 | Novartis Pharmaceuticals Corporation | KESIMPTA (Drug), MAYZENT | Food and Beverage | In-kind items and services | $16.06 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 11 | 616 | 770 | $105,635 | $46,658 |
| 2022 | 12 | 548 | 645 | $93,520 | $42,707 |
| 2021 | 11 | 488 | 3,716 | $142,279 | $56,469 |
| 2020 | 12 | 477 | 4,654 | $165,795 | $64,115 |
Total Patients
2,129
Total Services
9,785
Medicare Billing
$209,948
Procedure Codes
49
All Medicare Procedures & Services
49 procedure records from CMS Medicare Utilization — Page 1 of 2
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2023 | 116 | 176 | $17,776 | $11,845 | 66.6% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2023 | 110 | 110 | $25,850 | $10,762 | 41.6% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2023 | 135 | 213 | $27,457 | $6,920 | 25.2% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2023 | 51 | 54 | $12,570 | $5,110 | 40.7% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2023 | 63 | 68 | $6,392 | $3,092 | 48.4% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2023 | 38 | 38 | $3,646 | $2,669 | 73.2% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2023 | 34 | 34 | $3,060 | $2,056 | 67.2% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2023 | 14 | 14 | $2,380 | $1,545 | 64.9% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2023 | 21 | 21 | $2,693 | $1,356 | 50.4% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2023 | 23 | 23 | $2,588 | $1,040 | 40.2% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2023 | 11 | 19 | $1,224 | $263.40 | 21.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Facility | 2022 | 125 | 125 | $29,375 | $12,227 | 41.6% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Facility | 2022 | 109 | 162 | $16,496 | $10,838 | 65.7% |
| 95886 | Needle measurement of electrical activity in arm or leg muscles, complete study | Facility | 2022 | 108 | 142 | $18,269 | $4,862 | 26.6% |
| 95911 | Nerve conduction, 9-10 studies | Facility | 2022 | 47 | 47 | $10,785 | $4,713 | 43.7% |
| 99215 | Established patient office or other outpatient visit, 40-54 minutes | Facility | 2022 | 16 | 17 | $3,020 | $1,936 | 64.1% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Facility | 2022 | 36 | 37 | $3,478 | $1,624 | 46.7% |
| 95909 | Nerve conduction, 5-6 studies | Facility | 2022 | 26 | 26 | $2,453 | $1,610 | 65.7% |
| 95913 | Nerve conduction, 13 or more studies | Facility | 2022 | 11 | 11 | $2,475 | $1,601 | 64.7% |
| 95910 | Nerve conduction, 7-8 studies | Facility | 2022 | 25 | 25 | $2,250 | $1,498 | 66.6% |
| 95816 | Measurement of brain wave activity (eeg), awake and drowsy | Facility | 2022 | 21 | 22 | $2,475 | $939.73 | 38.0% |
| 99203 | New patient office or other outpatient visit, 30-44 minutes | Facility | 2022 | 11 | 11 | $1,287 | $579.73 | 45.0% |
| 95885 | Needle measurement of electrical activity in arm or leg muscles, limited study | Facility | 2022 | 13 | 20 | $1,157 | $278.60 | 24.1% |
| J0585 | Injection, onabotulinumtoxina, 1 unit | Office | 2021 | 12 | 3,200 | $41,600 | $15,447 | 37.1% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 105 | 121 | $24,232 | $9,512 | 39.3% |
About Dr. Omar Ahmad, MD
Dr. Omar Ahmad, MD is a Neurology healthcare provider based in Ontario, Ohio. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 03/23/2011. The National Provider Identifier (NPI) number assigned to this provider is 1922307453.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Omar Ahmad, MD has received a total of $8,706 in payments from pharmaceutical and medical device companies, with $117.06 received in 2024. These payments were reported across 141 transactions from 32 companies. The most common payment nature is "Consulting Fee" ($3,825).
As a Medicare-enrolled provider, Ahmad has provided services to 2,129 Medicare beneficiaries, totaling 9,785 services with total Medicare billing of $209,948. Data is available for 4 years (2020–2023), covering 49 distinct procedure/service records.
Ad
Practice Information
- Specialty Neurology
- Location Ontario, OH
- Active Since 03/23/2011
- Last Updated 10/09/2025
- Taxonomy Code 2084N0400X
- Entity Type Individual
- NPI Number 1922307453
Products in Payments
- Duopa (Drug) $4,850
- Infinity DBS Pulse Generators (Device) $1,762
- VNS Therapy (Device) $181.82
- KESIMPTA (Drug) $168.12
- UBRELVY (Drug) $161.66
- OCREVUS (Biological) $145.92
- AIMOVIG (Biological) $137.51
- AUSTEDO (Drug) $136.90
- QULIPTA (Drug) $119.12
- NUPLAZID (Drug) $97.80
- Neuromodulation Dspsbls and Accs (Device) $89.05
- Hizentra (Biological) $87.47
- Fycompa (Drug) $62.66
- BOTOX (Biological) $48.14
- NORTHERA (Drug) $40.41
- APOKYN (Drug) $37.65
- Briviact (Drug) $37.05
- Aimovig (Biological) $32.47
- TROKENDI XR (Drug) $29.38
- Radicava (Drug) $27.26
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.